This compound is a protected intermediate for the synthesis of nucleoside analogs. It features a modified pyrimidine base and a protected ribose-like core, commonly employed in pharmaceutical research and manufacturing processes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Molnupiravir
pharmaceutical raw material
XMO
pharmaceutical raw material
5-amino-1,3,4-thiadiazole-2-thiol
pharmaceutical intermediate
O-Methyl (S)-Noradrenaline
pharmaceutical intermediate
1-(2,3-Dichloro-4-hydroxyphenyl)butan-1-one
pharmaceutical intermediate
6-tert-butyl-3-(chloromethyl)-2,4-dimethylphenol
pharmaceutical intermediate
[(3aR,4R,6R,6aR)-4-[4-(hydroxyamino)-2-oxopyrimidin-1-yl]-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methyl 2-methylpropanoate
MNKXNZQOZRWRKB-OJAKKHQRSA-N
CC(C)C(=O)OC[C@@H]1[C@@H]2[C@H]([C@@H](O1)N3C=CC(=NC3=O)NO)OC(O2)(C)C
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.